Match Document Document Title Score
8658620 Pharmaceutical composition, use of 2-iminopyrrolidine derivative for production of pharmaceutical composition, and kit for treatment or amelioration of heart diseases  
One embodiment of the present invention is a pharmaceutical composition comprising at least one specific 2-iminopyrrolidine derivative and at least one other compound (B). Another embodiment of...
102
US20080166744 METHOD AND DEVICE FOR MONITORING INHIBITION OF PLATELET FUNCTION  
The invention provides a method of monitoring the response of platelets to a COX1 inhibitor such as aspirin. The method involves collecting platelet-containing mammalian blood treated with a COX1...
102
8431552 Composition for treating metabolic syndrome  
The invention relates to a composition that includes a first agent selected from the group consisting of an oxidative phosphorylation inhibitor, an ionophore, and an adenosine...
102
2003374 Preparation of calcium acetylsalicylate  
This invention relates to improvements in methods of preparing the calcium salt of acetylsalicylic acid. The invention also contemplates a more stable calcium acetylsalicylate than has heretofore...
102
5702697 Treatment for biological damage using a colony stimulating factor and a biological modifier  
Damage to cells, tissue and other body parts in a mammalian host may be treated by using a colony stimulating factor in conjunction with at least one biological modifier, which may be a free...
102
4151292 Composition and methods of use  
There is described a pharmaceutical composition comprising one or more of 1,3-bis(2-carboxychromon-5-yloxy)propan-2-ol; 5-(2-hydroxy-propoxy)-8-propyl-chromone-2-carboxylic acid;...
101
US20120179073 Ischemic Stroke Therapy  
A method for delivering ultrasound energy to a patient's intracranial space includes the steps of forming a hole in a patient's skull, locating an ultrasound transmitter near or into the hole, and...
101
US20040067261 Method for treating a mammal by administration of a compound having the ability to release CO, compounds having the ability to release CO and pharmaceutical compositions thereof  
Several classes of in vivo carbon monoxide-releasing compounds are useful for the treatment and/or prevention of diseases, such as chronic inflammatory, e.g., rheumatoid arthritis, and of diseases...
101
8652520 Combination tablet with chewable outer layer  
A pharmaceutical composition in the form of a combination tablet is described. The tablet has a rapidly absorbed component that enters the circulation by traversing the buccal mucosa, oral mucosa...
101
US20050148554 Anti-inflammatory and anti-thrombotic compounds and their compositions  
The invention encompasses novel compounds of Formula I, which are anti-inflammatory and anti-thrombotic agents. The invention also encompasses certain pharmaceutical compositions and methods for...
100
US20190008819 Methods and Compositions Using Cetyl Myristoleate (CMO) In Medical Treatments  
A therapeutic method of alleviating the symptoms of failed back surgery syndrome, post laminectomy syndrome, post-surgery syndrome, sympathetic dystrophies, macular degenerations, complex regional...
100
US20060058363 Nitric oxide releasing selective cyclooxygenase-2 inhibitors  
The invention encompasses novel compounds of Formula (I) and Formula (II), which are nitric oxide-releasing prodrugs useful in the treatment of cyclooxygenase-2 mediated diseases. The invention...
100
US20110275789 Methods and Kits for Detection of Thromboxane A2 Metabolites  
Methods, compositions and kits are provided for measuring aspirin's anti-thrombotic effectiveness on a subject. Included are a novel assay for quickly and specifically measuring TxA2 metabolite...
100
4324904 Processes for the preparation of hydratropic acids and esters  
The invention concerns the novel compounds dialkyl 2-(3-fluoro-4-nitrophenyl)-2-methylmalonate IIIa and dialkyl 2-(3-fluoro-4-aminophenyl)-2-methylmalonate IVa useful as intermediates in an...
100
4266069 Processes for the preparation of hydratropic acids and esters  
The invention concerns the novel compounds dialkyl 2-(3-fluoro-4-nitrophenyl)-2-methylmalonate IIIa and dialkyl 2-(3-fluoro-4-aminophenyl)-2-methylmalonate IVa useful as intermediates in an...
100
4398035 Malonic acids and esters thereof  
The invention concerns the novel compounds dialkyl 2-(3-fluoro-4-nitrophenyl)-2-methylmalonate IIIa and dialkyl 2-(3-fluoro-4-aminophenyl)-2-methylmalonate IVa useful as intermediates in an...
100
US20050255534 Method and device for monitoring asprin response  
The invention provides a method of monitoring the response of platelets to a COX1 inhibitor such as aspirin. The method involves collecting platelet-containing mammalian blood treated with a COX1...
100
3988466 Prevention of gastric lesions  
Gastric lesions induced by anti-inflammatory agents such as aspirin and indomethacin are prevented by the administration of amino acids. An anti-inflammatory composition comprising an...
100
4722938 Methods for using musculoskeletal relaxants  
Novel pharmaceutical analgesic, anti-inflammatory and skeletal muscle relaxant compositions and methods of using same comprising an analgesically and anti-inflammatory effective amount of at least...
100
4780463 Analgesic, anti-inflammatory and skeletal muscle relaxant compositions comprising non-steroidal anti-inflammatory drugs and musculoskeletal relaxants and methods of using same  
Novel pharmaceutical analgesic, anti-inflammatory and skeletal muscle relaxant compositions and methods of using same comprising an analgesically and anti-inflammatory effective amount of at least...
100
4923898 Analgesic, anti-inflammatory and skeletal muscle relaxant compositions comprising non-steroidal anti-inflammatory drugs and musculoskeletal relaxants and methods of using same  
Novel pharmaceutical analgesic, anti-inflammatory and skeletal muscle relaxant compositions and methods of using same comprising an analgesically and anti-inflammatory effective amount of at least...
100
7205115 Method and system for stabilization of arachidonic acid for use in platelet function assay  
Methods and systems for rapidly determining the level of platelet inhibition in whole blood, due to aspirin usage, with a single use arachidonic based assay device that can be stored at room...
99
US20110212904 GALACTOSYLATED PRO-DRUGS OF NON-STEROIDAL ANTI-INFLAMMATORIES WITH IMPROVED PHARMACOKINETIC CHARACTERISTICS AND REDUCED TOXICITY OF THE STARTING DRUG  
Pro-drugs of all non-steroidal anti-inflammatories with free acid function derivatized with an ester group, which have the general structural formula given below (I) where A is: aspirin,...
99
4829064 Cough/cold mixtures comprising non-sedating antihistamine drugs  
Pharmaceutical compositions and methods of using same comprising aspirin, sodium salicylate, salicylamide or acetaminophen, in combination with a non-sedating antihistamine and optionally one or...
99
2158091 Stabilized salts of acetyl salicylic acid  
This invention relates to medicines and pharmaceutical products particularly to stabilized salts of acetyl salicylic acid commonly known as aspirin. The advantages of such salts e. g. calcium and...
98
4613498 Hemorrhoid medication  
An anorectal medication for the treatment of hemorrhoids utilizing a mixture of ingredients in an ointment base. A powdered mixture of alum, quinine sulfate and aspirin is mixed with petroleum...
98
8404275 Combination tablet with chewable outer layer  
A pharmaceutical composition in the form of a combination tablet is described. The tablet has a rapidly absorbed component that enters the circulation by traversing the buccal mucosa, oral mucosa...
98
US20060246527 Method and system for stabilization of arachidonic acid for use in platelet function assay  
Methods and systems for rapidly determining the level of platelet inhibition in whole blood, due to aspirin usage, with a single use arachidonic based assay device that can be stored at room...
98
US20060148900 Method for treating a mammal by administration of a compound having the ability to release CO, compounds having the ability to release CO and pharmaceutical compositions thereof  
Several classes of in vivo carbon monoxide-releasing compounds are useful for the treatment and/or prevention of diseases, such as chronic inflammatory, e.g., rheumatoid arthritis, and of diseases...
98
US20060233890 Method for treating a mammal by administration of a compound having the ability to release CO  
Several classes of in vivo carbon monoxide-releasing compounds are useful for the treatment and/or prevention of diseases, such as chronic inflammatory, e.g., rheumatoid arthritis, and of diseases...
98
US20090029952 UNIQUE COMBINATION OF ACETYLSALICYLIC ACID, ETHYLENEDIAMINE DIHYDROIODIDE (EDDI), AND BUFFER FOR USE IN ANIMAL DRINKING WATER  
A unique combinations include acetylsalicylic acid (aspirin), ethylenediamine dihydriodide (EDDI), potassium iodide, sodium acetate, and sodium diacetate, useful in helping poultry, swine, and...
98
2052663 Ammonium salts of acetyl salicylic acid  
This invention relates to ammonium- salts of acetyl salicylic acid. The analgesic, antipyretic and antirheumatic therapeutic value of acetyl salicylic acid, more popularly known as aspirin, has...
98
8722654 Lipoxin analogs as novel inhibitors of angiogenesis  
The present invention is generally drawn to novel isolated therapeutic agents, termed lipoxins, generated from the interaction between a dietary omega-6 polyunsaturated fatty acid (PUFA) such as...
97
2474005 2-acetoxybenzyl acetylsalicylate  
It is an object of this invention to produce a new analgesic having substantial effectiveness over a prolonged period. As is well known, aspirin and related analgesics are effective for but short...
97
US20180296489 CAPSULE WITH INTERNAL DIAPHRAGM AND SOLID INGREDIENTS  
A two-compartment capsule includes a body, a diaphragm between, which seals off the body and provides a first compartment to hold a first dry ingredient, and a cap applied to the body whereby a...
97
4783551 Potassium acetylsalicylate addition compound and process of preparing  
The invention is drawn to a compound of the formula ##STR1## which can be prepared by the reaction of acetylsalicylic acid with potassium carbonate or potassium bicarbonate in the presence of...
96
3829569 THERAPEUTIC COMPOSITION AND METHOD FOR ITS USE  
A therapeutic composition for combatting all of the major symptoms resulting from the overindulgence of alcoholic beverages comprising a two-part formulation one part of which contains aspirin and...
96
US20020092792 Golf emergency kit  
A golf emergency kit that comprises a variety of articles stored in a case. The case, having a top compartment and a bottom compartment, is constructed of a durable plastic. It is compact to...
96
US20060052437 Combination of an hmg-coa reductase inhibitor and a nitrate ester  
The present invention relates to the therapeutical combination of an HMG-CoA reductase inhibitor (statin) and a nitrate ester and is useful mainly for the preparation of medicaments for the...
96
US20180015089 METHOD OF TREATING OR PREVENTION OF ATHEROTHROMBOTIC EVENTS IN PATIENTS WITH HISTORY OF MYOCARDIAL INFARCTION  
The present disclosure relates to methods for reducing the rate of cardiovascular death, myocardial infarction, or stroke in a patient in recognized need thereof, comprising administering to the...
95
5985860 System for transdermal delivery of pain relieving substances  
Compositions for pain relieving non-steroidal anti-inflammatory drugs and/or medicaments such as ibuprofen, methotrexate, capsaicin, diphenhydramine, aspirin, methyl-nicotinate and other...
95
5318960 System for transdermal delivery of pain relieving substances  
Compositions for pain relieving non-steroidal anti-inflammatory drugs and/or medicaments such as ibuprofen, methotrexate, capsaicin, diphenhydramine, aspirin, methylnicotinate and other...
95
US20130189361 COMBINATION TABLET WITH CHEWABLE OUTER LAYER  
A pharmaceutical composition in the form of a combination tablet is described. The tablet has a rapidly absorbed component that enters the circulation by traversing the buccal mucosa, oral mucosa...
95
2159214 Double salt of calcium ascorbate and calcium acetylsalicylate and process of making same  
My invention relates to pharmaceuticals and particularly to acetylsalicylic acid, commonly known as aspirin, which is widely recognized as a therapeutic agent. It is the object of my invention to...
95
US20130243859 ORALLY DISINTEGRATING TABLET  
The present invention relates to a multi-layer orally disintegrating tablet having (1) an enteric fine granule-containing layer containing a proton pump inhibitor and (2) an acetylsalicylic...
95
4514421 Dietary and pharmaceutical uses of methylsulfonylmethane and compositions comprising it  
Methylsulfonylmethane (CH3 SO2 CH3) administered orally is effective in ameliorating the symptoms of gastrointestinal upset, e.g., produced by the ingestion of aspirin and other pharmaceuticals,...
95
4287174 Anti-ulcer composition  
Zwitterionic surfactant compounds provide effective therapy for ulceration of the gastric mucosa. The tendency of aspirin and other salicylate-based drugs to cause ulceration of the gastric mucosa...
95
2234316 Vending machine  
My invention relates to new and useful improvements in vending machines. An important object of my invention is to provide a vending machine that is adapted to contain a plurality of small...
95
2385365 Salicylic acid compounds for safer therapeutic use  
My invention relates to the reduction of danger in the therapeutic use of salicylic acid compounds. Salicylip acid compounds stands high as beneficial drugs, and are among the most widely used of...
95
2325529 Cough drop  
This invention relates to a cough drop and to a method of making it, and more particularly to a cough drop containing acetyl salicylic acid or aspirin. Among the objects of this invention are the...
94


Search
« search again